3638 results for «213»

Filter By

3638 results

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

TAVI and coronary artery disease - LIVE case

19 May 2026 – From EuroPCR 2026

An 88-year-old woman with hypertension, dyslipidemia, paroxysmal AF, and moderate renal impairment presented with symptomatic severe aortic stenosis, with a small (396 mm²), horizontal annulus and preserved LV function. She also had CAD with severe OM and diagonal stenoses. CT showed a risk of left main...

TAVI and coronary artery disease - LIVE case

PCI of calcified distal left main stenosis - LIVE case

19 May 2026 – From EuroPCR 2026

A 54 year-old male with hypertention, smoker, dyslipidemia and history of OM and Diagnal PCI (2004) presented a significant LM-LAD calcified stenosis.

They prepared the proximal LAD lesion by IVL before implanted a 3.5-28 mm stent. Then, they prepared the LM lesion with NC predilatation, a cutting...

PCI of calcified distal left main stenosis - LIVE case

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

19 May 2026 – From EuroPCR 2026

A 71‑year‑old man with hypertension and dyslipidemia presented with CCS class II angina and three‑vessel coronary artery disease. Functional assessment included CT‑derived micro‑FFR, angiography‑based FFR, and stress myocardial scintigraphy. The only hemodynamically significant lesion was a long, calcified lesion of the LAD.

Lesion preparation was performed with...

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

TAVI in aortic regurgitation with a dedicated valve - LIVE case

20 May 2026 – From EuroPCR 2026

An 80-year-old male with chronic kidney disease, a history of colon cancer (2013), paroxysmal AF, and LAD PCI 2 weeks earlier presented with symptomatic severe type III AR. He had normal LV function, but early LV dilation. The mechanism of AR was a combination of primary...

TAVI in aortic regurgitation with a dedicated valve - LIVE case

Combined mitral repair and LAA closure with two separate septal punctures - LIVE case

21 May 2026 – From EuroPCR 2026

A 79‑year‑old man with hypertension, a history of basal cell carcinoma and psoriasis, presented with symptomatic severe primary MR (flail P2 due to ruptured chordae) and bleeding complications (recurrent skin bleeding) while on DOAC therapy for permanent atrial fibrillation.

Two G5 MitraClip devices were implanted. Subsequently, through...

Combined mitral repair and LAA closure with two separate septal punctures - LIVE case

Calcified lesion of distal protected left main - LIVE case

22 May 2026 – From EuroPCR 2026

An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...

Calcified lesion of distal protected left main - LIVE case

TAV-in-SAV TAVI procedure - LIVE case

21 May 2026 – From EuroPCR 2026

A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...

TAV-in-SAV TAVI procedure - LIVE case

TAVI in extensive valve calcifications - LIVE case

22 May 2026 – From EuroPCR 2026

An 88‑year‑old woman with a history of dual‑chamber PPM and prior radiotherapy for breast cancer presented with symptomatic aortic stenosis and preserved left ventricular function.

A 27 mm Navitor Vision valve was implanted under local anesthesia using dual arterial access (femoral and right radial arteries).

LIVE Educational Case...

TAVI in extensive valve calcifications - LIVE case

POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

02 Sep 2024

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Luis Ortega-Paz

Author

Luis Ortega-Paz
POPular PAUSE TAVI

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

29 Oct 2024

Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.

Luigi Biasco

Author

Luigi Biasco
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
Live from ACC.23/WCC: TRILUMINATE pivotal

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
Didn’t find what you were looking for?